StockData
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN) income statement

DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.02−0.30 (-3.22%)

Close on Nov 20, 2026Market cap $564.49MP/E –Yield –

See a number that looks wrong?